This topic contains a solution. Click here to go to the answer

Author Question: What best describes the relationship between ethnicity and mortality in America today? A) ... (Read 6 times)

evelyn o bentley

  • Hero Member
  • *****
  • Posts: 564
What best describes the relationship between ethnicity and mortality in America today?
 
  A) Ethnicity is related to life expectancy, but not to cause of death.
  B) Ethnicity is related to cause of death, but not to life expectancy.
  C) Ethnicity is related to both life expectancy and to cause of death.
  D) Ethnicity is related to neither life expectancy nor cause of death.

Question 2

The single most important contributor to an increase in life expectancy is
 
  A) the decrease in the infant mortality rate.
  B) the increase in individuals' beliefs in the importance of exercise.
  C) advancement in medical technology.
  D) advancement in medical care.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joanwhite

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

C

Answer to Question 2

A




evelyn o bentley

  • Member
  • Posts: 564
Reply 2 on: Jun 21, 2018
:D TYSM


jamesnevil303

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library